Arch Venture Corp »

Revolution Medicines shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $93M 3.2M 28.68

More positions owned by Arch Venture Corp

Revolution Medicines (RVMD)
Verve Therapeutics (VERV)
Erasca (ERAS)
Denali Therapeutics (DNLI)
Gossamer Bio (GOSS)
Unity Biotechnology (UBX)
Singular Genomics Systems In (OMIC)

View all positions for Arch Venture Corp

Top funds holding Revolution Medicines

Wellington Management Company
Vanguard Group
Nextech Invest
BVF
Casdin Capital
Alphabet
Baker Bros. Advisors
Bellevue Group
T. Rowe Price Associates
Jpmorgan Chase & Co
Boxer Capital
Arch Venture Corp
Deerfield Management Company
Holocene Advisors
Henderson Group

View all funds holding Revolution Medicines